Nambi P, Mattern M, Bartus J O, Aiyar N, Crooke S T
Department of Molecular Pharmacology, SK&F Laboratories, Philadelphia, PA 19406-2799.
Biochem J. 1989 Sep 1;262(2):485-9. doi: 10.1042/bj2620485.
Incubation of cultured rat aortic smooth muscle cells (A-10, ATCC CRL 1476) with [8-arginine]vasopressin (AVP) or thrombin increased the amount of DNA strand breakage induced by camptothecin, an inhibitor of topoisomerase I (DNA topoisomerase; EC 5.99.1.2) and transiently stimulated the extractable activity of this enzyme. Both topoisomerase-related responses were prevented by treatment of the cells with AVP or thrombin plus the appropriate receptor antagonist. The increase in strand breakage mediated by AVP and thrombin depended on the concentration of hormone. Neither AVP nor thrombin had any effect on strand breaks obtained with the epipodophyllotoxin VM-26, an inhibitor of topoisomerase II [DNA topoisomerase (ATP-hydrolysing); EC 5.99.1.3]. Pretreatment of the cells with pertussis toxin partially inhibited thrombin-mediated increases in camptothecin-induced strand breakage whereas AVP-mediated increases were unaffected. These results are consistent with the notion that AVP and thrombin induce a transient increase in intracellular topoisomerase I activity via interactions with their respective cell surface receptors and that the effects of the activation of these receptors are mediated by different G-proteins.
用[8-精氨酸]血管加压素(AVP)或凝血酶孵育培养的大鼠主动脉平滑肌细胞(A-10,美国典型培养物保藏中心CRL 1476),可增加喜树碱(一种拓扑异构酶I抑制剂;DNA拓扑异构酶;EC 5.99.1.2)诱导的DNA链断裂量,并短暂刺激该酶的可提取活性。用AVP或凝血酶加相应受体拮抗剂处理细胞可阻止这两种与拓扑异构酶相关的反应。AVP和凝血酶介导的链断裂增加取决于激素浓度。AVP和凝血酶对用表鬼臼毒素VM-26(一种拓扑异构酶II抑制剂;DNA拓扑异构酶(ATP水解);EC 5.99.1.3)获得的链断裂均无影响。用百日咳毒素预处理细胞可部分抑制凝血酶介导的喜树碱诱导的链断裂增加,而AVP介导的增加不受影响。这些结果与以下观点一致:AVP和凝血酶通过与其各自的细胞表面受体相互作用诱导细胞内拓扑异构酶I活性短暂增加,且这些受体激活的效应由不同的G蛋白介导。